Cardiac hypertrophy is a major pathological response to cardiovascular stress and a critical contributor to heart failure (HF). Gentiopicroside (GPS), a naturally occurring iridoid glycoside derived from Gentiana scabra, exhibits anti-inflammatory, antioxidant, and anti-fibrotic properties. However, its role and molecu...
Ming-Zhen Cao, Da Ke, Jian Ni et al.· Phytotherapy Research· 0 citations
In male mice with established two-hit HFpEF, autotaxin inhibition improved diastolic indices and reduced fibrosis, hypertrophy and cardiac myeloid accumulation and the autotaxin–LPA axis is nominated as a tractable therapeutic target.
Rajesh Chaudhary, Andrew Robbins, A. Singh et al.· bioRxiv· 0 citations
BACKGROUND
Post-myocardial infarction heart failure (post-MI HF) is driven by adverse ventricular remodeling and mitochondrial dysfunction. Cardiolipin is essential for mitochondrial integrity, but its upstream regulation in failing myocardium remains unclear. Whether Hongqi Shenmai Decoction (HQSMD) preserves cardioli...
Hao Bo, Da Liu, Chunxia Zhai et al.· Phytomedicine· 0 citations
In a multihit HFpEF model, urolithin A improved diastolic function and attenuated cardiac remodeling through cysteine 42–dependent activation of PKGIα, and was validated in human engineered heart tissue, where urolithin A enhanced both relaxation and contraction kinetics.
J. Su, Yue Zhao, Pierre Coleman et al.· Science Advances· 1 citation
BACKGROUND: Endothelial defects in the heart are a contributor to cardiac pathological remodeling and dysfunction, which can be influenced by cardiomyocytes. Here, we explore cardioprotective crosstalk between cardiomyocytes and endothelial cells under diabetic conditions. METHODS: Type 2 diabetes was induced in male a...
S. Gare, N. H. Alatawi, Xin-Yi Chen et al.· Circulation Research· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.